Adial Pharmaceuticals, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Adial Pharmaceuticals, Inc. (ADIL) reported Adjustments to Additional Paid in Capital, Warrant Issued of $3.38 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2025-03-04
- Adial Pharmaceuticals, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2019-03-31 was $441.76K.
- Adial Pharmaceuticals, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2018-12-31 was $0.00.
- Adial Pharmaceuticals, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2018-09-30 was $0.00.
- Adial Pharmaceuticals, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $3.38M.
- Adial Pharmaceuticals, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2019 was $441.76K, a 98.14% increase from fiscal 2018.
- Adial Pharmaceuticals, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2018 was $222.95K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2023-12-31 | $3.38M 10-K · filed 2025-03-04 | |||
| 2019-12-31 | $441.76K 10-K · filed 2021-03-22 | |||
| 2019-03-31 | $441.76K 10-Q · filed 2020-11-13 | $441.76K derived: sum of 2 quarters · filed 2020-11-13 | $441.76K derived: sum of 3 quarters · filed 2020-11-13 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $0.00 derived: sum of 2 quarters · filed 2019-02-19 | $222.95K 10-K · filed 2019-02-19 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $222.95K 10-Q · filed 2018-11-14 | ||
| 2018-06-30 | $222.95K 10-Q · filed 2018-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |